BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: El-Shamy A, Hotta H. Impact of hepatitis C virus heterogeneity on interferon sensitivity: An overview. World J Gastroenterol 2014; 20(24): 7555-7569 [PMID: 24976696 DOI: 10.3748/wjg.v20.i24.7555]
URL: https://www.wjgnet.com/1948-5182/full/v20/i24/7555.htm
Number Citing Articles
1
Abd Elrazek Abd Elrazek, Shymaa E. Bilasy, Abduh E. M. Elbanna, Abd Elhalim A. Elsherif. Prior to the Oral Therapy, What Do We Know About HCV-4 in EgyptMedicine 2014; 93(28): e204 doi: 10.1097/MD.0000000000000204
2
Sonia Lozano-Sepulveda, Owen Bryan-Marrugo, Jose Merino-Mascorro, Ana Maria Rivas-Estilla. Approachability to the new anti-HCV direct acting antiviral agents in the Latin American contextFuture Virology 2016; 11(1): 39 doi: 10.2217/fvl.15.97
3
Ahmed El-Shamy, Matthew Pendleton, Francis J. Eng, Erin H. Doyle, Ali Bashir, Andrea D. Branch. Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patientsScientific Reports 2016; 6(1) doi: 10.1038/srep27025
4
Yo-ichi Ishida, Masahiko Takeshita, Hiroaki Kataoka. Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanismWorld Journal of Hepatology 2014; 6(12): 870-879 doi: 10.4254/wjh.v6.i12.870
5
Ahmed El-Shamy, Francis J. Eng, Erin H. Doyle, Arielle L. Klepper, Xiaochen Sun, Angelo Sangiovanni, Massimo Iavarone, Massimo Colombo, Robert E. Schwartz, Yujin Hoshida, Andrea D. Branch. A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core geneJournal of Hepatology 2015; 63(6): 1323 doi: 10.1016/j.jhep.2015.07.024
6
Sylvie Larrat, Om Kulkarni, Jean-Baptiste Claude, Réjane Beugnot, Michaël G. B. Blum, Katia Fusillier, Julien Lupo, Pauline Tremeaux, Agnès Plages, Alice Marlu, Hervé Duborjal, Anne Signori-Schmuck, Olivier Francois, Jean-Pierre Zarski, Patrice Morand, Vincent Leroy, M. J. Loeffelholz. Ultradeep Pyrosequencing of NS3 To Predict Response to Triple Therapy with Protease Inhibitors in Previously Treated Chronic Hepatitis C PatientsJournal of Clinical Microbiology 2015; 53(2): 389 doi: 10.1128/JCM.02547-14
7
Megumi Tasaka-Fujita, Nao Sugiyama, Wonseok Kang, Takahiro Masaki, Asako Murayama, Norie Yamada, Ryuichi Sugiyama, Senko Tsukuda, Koichi Watashi, Yasuhiro Asahina, Naoya Sakamoto, Takaji Wakita, Eui-Cheol Shin, Takanobu Kato. Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule ExpressionScientific Reports 2015; 5(1) doi: 10.1038/srep13994
8
Ryuichi Sugiyama, Asako Murayama, Sayuri Nitta, Norie Yamada, Megumi Tasaka-Fujita, Takahiro Masaki, Hussein Hassan Aly, Masaaki Shiina, Akihide Ryo, Koji Ishii, Takaji Wakita, Takanobu Kato. Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signalingOncotarget 2018; 9(5): 5627 doi: 10.18632/oncotarget.23562
9
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatmentWorld Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
10
Stacy M. Horner. Insights into antiviral innate immunity revealed by studying hepatitis C virusCytokine 2015; 74(2): 190 doi: 10.1016/j.cyto.2015.03.007
11
Mohamed M Adel El-Sokkary, Lizaveta Gotina, Mohammad M. Al-Sanea, Ae Nim Pae, Rehab Mohammed Elbargisy. <p>Molecular Characterization of Hepatitis C Virus for Developed Antiviral Agents Resistance Mutations and New Insights into in-silico Prediction Studies</p>Infection and Drug Resistance 2020; : 4235 doi: 10.2147/IDR.S267809
12
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in IranWorld Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
13
Tayebeh Hashempour, Behzad Dehghani, Zahra Mousavi, Tahereh Akbari, Zahra Hasanshahi, Javad Moayedi, Maryam Yahaghi, Mohammad Ali Davarpanah. Association of Mutations in the NS5A-PKRBD Region and IFNL4 Genotypes with Hepatitis C Interferon Responsiveness and its Functional and Structural AnalysisCurrent Proteomics 2021; 18(1): 38 doi: 10.2174/1570164617666200107091124
14
Mohammed El-Mowafy, Abdelaziz Elgaml, Mohamed El-Mesery, Salma Sultan, Tamer A. E. Ahmed, Ahmed I. Gomaa, Mahmoud Aly, Walid Mottawea. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus InfectionBiology 2021; 10(1): 55 doi: 10.3390/biology10010055
15
Shaogeng Zhang, Fang Sun, Tianyu Ren, Yueqiang Duan, Hongjing Gu, Chengcai Lai, Zhaohai Wang, Peirui Zhang, Xiliang Wang, Penghui Yang. Immunogenicity of an influenza virus-vectored vaccine carrying the hepatitis C virus protein epitopes in miceAntiviral Research 2017; 145: 168 doi: 10.1016/j.antiviral.2017.07.015
16
F. A. Di Lello, J. A. Mira, K. Neukam, M. Parra-Sánchez, J. R. Guelfo, C. Cifuentes, J. Macías, J. C. Palomares, J. Gómez-Mateos, J. A. Pineda, Luis M. Real. Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infectionArchives of Virology 2014; 159(12): 3345 doi: 10.1007/s00705-014-2209-x
17
Claire Gondeau, Georges Philippe Pageaux, Dominique Larrey. Hepatitis C virus infection: Are there still specific problems with genotype 3?World Journal of Gastroenterology 2015; 21(42): 12101-12113 doi: 10.3748/wjg.v21.i42.12101
18
Sonia A Lozano-Sepulveda, Owen L Bryan-Marrugo, Carlos Cordova-Fletes, Maria C Gutierrez-Ruiz, Ana M Rivas-Estilla. Oxidative stress modulation in hepatitis C virus infected cellsWorld Journal of Hepatology 2015; 7(29): 2880-2889 doi: 10.4254/wjh.v7.i29.2880
19
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidicsAnalytical Methods 2021; 13(6): 740 doi: 10.1039/D0AY02045A
20
V. S. Kichatova, A. A. Karlsen, O. V. Isaeva, S. A. Solonin, E. Yu. Malinnikova, K. K. Kyuregyan, M. I. Mikhailov. Drug resistant variants of hepatitis C virus genotype 1b in Russia: analysis of aminoacid substitutions in NS5a and core proteinsJournal Infectology 2018; 10(4): 30 doi: 10.22625/2072-6732-2018-10-4-30-36
21
Mathieu Larocque, Thierry Chénard, Rafael Najmanovich. A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitorsBMC Systems Biology 2014; 8(1) doi: 10.1186/s12918-014-0117-z
22
Manola Comar, Francesco De Seta, Nunzia Zanotta, Serena Del Bue, Pasquale Ferrante. Sexually Transmitted Infections2020; : 107 doi: 10.1007/978-3-030-02200-6_6
23
Thu Kim Nguyen, Duyet Van Le. Identification of NS5B Resistance-Associated Mutations in Hepatitis C Virus Circulating in Treatment Naïve Vietnamese PatientsInfection and Drug Resistance 2022; : 1547 doi: 10.2147/IDR.S353605
24
Supiana Dian Nurtjahyani, Rasyadan Taufiq Probojati, Arif Nur Muhammad Ansori, Mochammad Amin, Retno Handajani. Haplotype Network Analysis and Phylogenetic Tree Construction of Hepatitis C Virus (HCV) Isolated from Tuban, IndonesiaResearch Journal of Pharmacy and Technology 2021; : 4231 doi: 10.52711/0974-360X.2021.00734
25
Camelia Sultana, Gabriela Oprişan, Monica Delia Teleman, Sorin Dinu, Cristiana Oprea, Mihai Voiculescu, Simona Ruta. Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis CWorld Journal of Gastroenterology 2016; 22(37): 8406-8413 doi: 10.3748/wjg.v22.i37.8406
26
Rafael Alves da Silva, Isabel Maria Vicente Guedes de Carvalho, Renata Prandini Adum de Matos, Lilian Hiromi Tomonari Yamasaki, Cíntia Bittar, Paula Rahal, Ana Carolina Gomes Jardim. Evidence of bottleneck effect on hepatitis C virus transmission between a couple under interferon based therapyInfection, Genetics and Evolution 2017; 47: 87 doi: 10.1016/j.meegid.2016.11.012
27
Malik Sallam, Rawan Batarseh, Anas Natsheh, Jumana Abbadi, Esraa Al-Fraihat, Alaa’ Yaseen, Doaa Kaddomi, Nadia Khamees, Azmi Mahafzah, Gülşen Özkaya Şahin. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in AmmanBMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4735-3
28
Edward C. Mader, Wael Richeh, Joaquin Maury Ochoa, Lacey L. Sullivan, Amparo N. Gutierrez, Jesus F. Lovera. Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?Journal of the Neurological Sciences 2015; 349(1-2): 239 doi: 10.1016/j.jns.2014.12.034
29
Dougbeh-Chris Nyan, Kevin L. Swinson. A method for rapid detection and genotype identification of hepatitis C virus 1–6 by one-step reverse transcription loop-mediated isothermal amplificationInternational Journal of Infectious Diseases 2016; 43: 30 doi: 10.1016/j.ijid.2015.12.002
30
Rafael Alves da Silva, Jardelina de Souza Todão, Fernando Luiz Kamitani, Antonio Eduardo Benedito Silva, Roberto José de Carvalho-Filho, Maria Lucia Cardoso Gomes Ferraz, Isabel Maria Vicente Guedes de Carvalho. Molecular characterization of hepatitis C virus in end-stage renal disease patients under hemodialysisJournal of Medical Virology 2018; 90(3): 537 doi: 10.1002/jmv.24976
31
V. S. Kichatova, K. K. Kyuregyan, N. V. Soboleva, A. A. Karlsen, O. V. Isaeva, M. G. Isaguliants, M. I. Mikhailov. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic ContextJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/7685371